Catharine West

25PUBLICATIONS
291CO-AUTHORS
Predictive and prognostic markersRadiation therapyGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 26, 2026
A plasma derived hypoxia signature predicts benefit from hypoxia-modifying radiotherapy and reveals dynamic humoral immune modulation in bladder cancer.

|Jul 13, 2026
Circadian Genotypes in PER3 and Time of Prostate Cancer Radiotherapy Interact to Affect Risk of Late Side Effects.

|Apr 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients.

|Apr 01, 2026
Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicity.

Hanan Abumanhal-Masarweh, Salam A Assi, Xinming Liu

|Jan 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.

Jason L Vassy, Anna M Dornisch, Roshan Karunamuni

|Oct 13, 2025
Integration of Dose Surface Maps and Genetic Data Identifies the Lower Posterior Rectum as a Key Region for Toxicity after Prostate Cancer Radiotherapy.

Artemis Bouzaki, Eliana Vasquez Osorio, Sarah Kerns

Pageof 5

Frequent Collaborators

11 joint publications

Ana Vega

7 joint publications

Alison M Dunning

6 joint publications

Ruth C Travis

6 joint publications

Henrik Gronberg